OIG Warns Pharmaceutical Manufacturers of Improper Part D Beneficiary Coupon Use

Published date06 October 2014
Law FirmEpstein Becker & Green
AuthorAlan Arville,Constance Wilkinson,Benjamin Zegarelli
Subject MatterMedicare,Medicare Part D,OIG,Pharmaceutical Industry,Pharmacies,Prescription Drugs

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT